Sava Infond d.o.o. Purchases Shares of 9,540 Intuitive Surgical, Inc. (NASDAQ:ISRG)

Sava Infond d.o.o. purchased a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 9,540 shares of the medical equipment provider’s stock, valued at approximately $4,979,000. Intuitive Surgical accounts for 0.9% of Sava Infond d.o.o.’s investment portfolio, making the stock its 21st largest holding.

Several other institutional investors also recently modified their holdings of the business. Vanguard Group Inc. raised its position in Intuitive Surgical by 1.1% during the 4th quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider’s stock worth $16,813,478,000 after purchasing an additional 360,591 shares during the last quarter. State Street Corp increased its stake in shares of Intuitive Surgical by 1.4% in the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock valued at $7,393,673,000 after buying an additional 210,363 shares during the period. Geode Capital Management LLC raised its position in shares of Intuitive Surgical by 1.9% during the third quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider’s stock worth $3,677,194,000 after acquiring an additional 143,440 shares during the last quarter. Fisher Asset Management LLC raised its position in shares of Intuitive Surgical by 1.8% during the fourth quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider’s stock worth $2,541,356,000 after acquiring an additional 86,488 shares during the last quarter. Finally, Wellington Management Group LLP lifted its stake in shares of Intuitive Surgical by 1.7% in the third quarter. Wellington Management Group LLP now owns 3,115,024 shares of the medical equipment provider’s stock worth $1,530,318,000 after acquiring an additional 53,383 shares during the period. Institutional investors own 83.64% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on ISRG shares. Erste Group Bank lowered shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Monday, March 17th. JPMorgan Chase & Co. increased their price objective on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and boosted their target price for the company from $522.00 to $650.00 in a report on Monday, December 2nd. Wells Fargo & Company increased their price target on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Finally, Evercore ISI lifted their price objective on Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. One analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have given a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $611.86.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $509.03 on Thursday. The stock has a market cap of $181.31 billion, a price-to-earnings ratio of 79.41, a PEG ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The firm’s 50-day simple moving average is $559.82 and its 200 day simple moving average is $532.42.

Insider Transactions at Intuitive Surgical

In other news, CFO Jamie Samath sold 94 shares of the company’s stock in a transaction on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total value of $53,684.34. Following the completion of the sale, the chief financial officer now owns 2,630 shares in the company, valued at $1,502,019.30. This represents a 3.45 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the transaction, the director now directly owns 12,275 shares in the company, valued at $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 33,754 shares of company stock valued at $17,691,621 over the last ninety days. 0.90% of the stock is currently owned by insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.